Webcast Alert: AVANIR Pharmaceuticals Announces Its Second Quarter 2005 Conference Call Webcast

AVANIR Pharmaceuticals (AMEX: AVN) announces the
following Webcast:
   What: AVANIR Pharmaceuticals Second Quarter 2005 Conference Call
Webcast

   When: May 16, 2005 @ 04:30 PM Eastern

   Where: http://www.vcall.com/EventPage.asp?ID=91764

   How: Live over the Internet -- Simply log on to the web at the
address above.

   Contact: Patrice A Saxon, [phone] or [e-mail]

   If you are unable to participate during the live webcast, the call
will be available for replay at
http://www.vcall.com/ClientPage.asp?ID=91764 or http://www.vcall.com/
   AVANIR Pharmaceuticals is a drug discovery and development company
focused on developing and commercializing novel therapeutic products
for the treatment of chronic diseases. AVANIR's product candidates
address therapeutic markets that include central nervous system and
cardiovascular disorders, inflammation, and infectious disease. The
Company's first commercialized product, Abreva(R), is marketed in
North America by GlaxoSmithKline Consumer Healthcare and is the
leading over-the-counter product for the treatment of cold sores.
Further information about AVANIR can be found at www.avanir.com.